US2011159545A1PendingUtilityA1
Fungamyl-like Alpha-Amylase Variants
Est. expiryNov 10, 2019(expired)· nominal 20-yr term from priority
A21D 8/042C12Y 302/01001C12N 9/2417C13K 7/00C12C 11/00C12P 19/02C13K 1/06C12P 19/14Y02E50/10C12C 5/004C12N 9/242C12P 7/06
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a variant of a parent Fungamyl-like fungal alpha-amylase, which exhibits improved thermal stability at acidic pH suitable for, e.g., starch processes.
Claims
exact text as granted — not AI-modified1 . A variant of a parent Fungamyl-like alpha-amylase, comprising an alteration at one or more regions selected from the group of:
Region 98-110, Region 150-160, Region 161-167, Region 280-288, Region 448-455, Region 468-475. wherein (a) the alteration(s) are independently
(i) an insertion of an amino acid downstream of the amino acid which occupies the position,
(ii) a deletion of the amino acid which occupies the position, or
(iii) a substitution of the amino acid which occupies the position with a different amino acid, (b) the variant has alpha-amylase activity and (c) each region or position corresponds to a region position of the amino acid sequence of the parent Fungamyl-like alpha-amylase having the amino acid sequence of SEQ ID NO: 2.
2 . The variant of claim 1 , wherein the variant is one or more of the following substitution: Q153S.
3 . The variant of claim 1 , which variant has improved thermostability and/or increased stability at acidic pH.
4 . A DNA construct comprising a DNA sequence encoding an alpha-amylase variant of any of claims 1 - 3 .
5 . A recombinant expression vector which carries a DNA construct according to claim 4 .
6 . A cell which is transformed with a DNA construct according to claim 4 or a vector according to claim 5 .
7 . A cell according to claim 6 , wherein the cell is a microorganism, such as a bacterium or a fungus.
8 . The cell according to claim 7 , which is a protease deficient strain of Aspergillus , in particular A. oryzae.
9 . A composition for producing high maltose syrup comprising an Fungamyl-like alpha-amylase variant of claims 1 - 3 .
10 . The composition of claim 9 , further comprising beta-amylase activity.
11 . A dough improving composition, comprising an alpha-amylase variant of any of claims 1 - 3 .
12 . A brewing composition comprising an alpha-amylase variant of any of claims 1 - 3 .
13 . The brewing composition of claim 12 , further comprising one or ore enzymes selected from the group of beta-amylase and isoamylase.
14 . A composition for producing alcohol, comprising an alpha-amylase variant of any of claims 1 - 3 .
15 . A process of liquefying starch, wherein an alpha-amylase variant of claims 1 - 3 is used for treating starch.
16 . A process of producing high maltose syrups, wherein an alpha-amylase variant of claims 1 - 3 is used for liquefying starch.
17 . A brewing process, wherein an alpha-amylase variant of claims 1 - 3 is added during fermentation of wort.
18 . An alcohol production process, wherein an alpha-amylase variant of claim 1 - 3 is used for liquefaction starch in a distillery mash.
19 . A process, wherein a dough product comprising an alpha-amylase variant of claims 1 - 3 is baked.
20 . Use of an alpha-amylase variant of any of claims 1 - 3 or a composition of claim 9 for starch liquefaction.
21 . Use of an alpha-amylase variant of any of claims 1 - 3 or a composition of claim 9 for producing alcohol.
22 . Use of an alpha-amylase variant of any of claims 1 - 3 or a composition of claim 9 for brewing.
23 . Use of an alpha-amylase variant of any of claims 1 - 3 or a composition of claim 9 for baking.
24 . A method for generating an alpha-amylase variant of a parent Fungamyl-like alpha-amylase, which variant has increased thermostability, in particular at acidic pH relative to the parent, the method comprising:
(a) subjecting a DNA sequence encoding the parent Fungamyl-like alpha-amylase to random mutagenesis, (b) expressing the mutated DNA sequence obtained in step (a) in a host cell, and (c) screening for host cells expressing a mutated alpha-amylase which has improved thermostability at acidic pH relative to the parent Fungamyl-like alpha-amylase.
25 . Process for producing a maltose syrup comprising the steps of:
1) liquefying starch in the presence of an alpha-amylase, followed by 2) dextrinization the presence of a fungal alpha-amylase variant of claim 1 - 3 ; 3) recovery of the syrup; and optional purification.
26 . Process for producing syrup, in particular maltose syrup, comprising the steps of:
1) liquefying starch at a temperature of 140-160° C. at a pH of 4-6, followed by 2) dextrinization at a temperature in the range from 60-95° C. at a pH 4-6 in the presence of a fungal alpha-amylase variant of claims 1 - 3 ; and 3) recovery of the syrup; and optional purification.
27 . The process of claim 26 , wherein the liquefying starch is treated at a temperature of 65-85° C., in particular 70-80° C.
28 . The process of claim 27 , wherein an effective amount of glucoamylase is added in step 2).
29 . Process for producing maltose syrup, comprising the steps of:
1) liquefying starch at a temperature of 95-110° C. at a pH of 4-6 in the presence of a Bacillus alpha-amylase, followed by 2) dextrinization at a temperature in the range from 60-95° C. at a pH 4-6 in the presence of a fungal alpha-amylase variant of claims 1 - 3 ; and 3) recovery of the syrup; and optional purification.
30 . An immobilized variant of claims 1 - 3 .Join the waitlist — get patent alerts
Track US2011159545A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.